Application no. and date | 09752688.3 (espacenet) (Federated) (European Patent Register), 20091113 | Patent/reg. no. and date | DK/EP 2358675, 20121003 | Publication date | 20110824 | Priority no. and date | US 114541 P, 20081114 | EP pub. no. and date |
EP 2358675 20110824 | Effective date | | Applicant/owner | Theravance Biopharma R&D IP, LLC, 901 Gateway Boulevard
South San Francisco, CA 94080, US | Applicant ref. no. | 145585 | Inventor | LONG, Daniel D., 4358 23rd Street
San Francisco California 94114, US, STANGELAND, Eric L., 896 Corona Drive
Pacifica California 94044, US, PATTERSON, Lori Jean, 3 Whitney Street
San Francisco California 94131, US, ZIPFEL, Sheila, 112 E. Middlefield Road Unit B
Mountain View California 94043, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/4409 (2006.01) , A61P 25/00 (2006.01) , C07D 211/22 (2006.01) | Title | 4-[2-(2-Fluorphenoxymethyl)phenyl]piperidinforbindelser | Int. application no. | US2009064308 | Int. publication no. | WO2010056941 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|